T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
20 hedge funds and large institutions have $672K invested in T2 Biosystems, Inc in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 37 closing their positions.
296% more call options, than puts
Call options by funds: $111K | Put options by funds: $28K
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
63% less funds holding
Funds holding: 54 → 20 (-34)
76% less capital invested
Capital invested by funds: $2.84M → $672K (-$2.17M)
92% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 37
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ML
McAdam LLC
Philadelphia,
Pennsylvania
|
+$228K |
| 2 |
Bank of New York Mellon
New York
|
+$102K |
| 3 |
Group One Trading
Chicago,
Illinois
|
+$18.7K |
| 4 |
Morgan Stanley
New York
|
+$15.6K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
+$12.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$321K |
| 2 |
GS
Gagnon Securities
New York
|
-$87K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$39.4K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$32K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31.4K |
TTOO Hedge Fund Activity: Q4 2022 in Review
20 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q4 2022, worth a combined $672K — down 76% from $2.84M a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of TTOO and 3 opened new positions — a net loss of 34 holders — while 5 trimmed existing stakes and 7 added.
The largest buyer was McAdam LLC, adding an estimated $228K. The largest seller was Altium Capital Management, exiting entirely with an estimated $321K sold.
- 20 institutional investors held T2 Biosystems, Inc (TTOO) as of Q4 2022, down from 54 in Q3 2022.
- Funds reported $672K of T2 Biosystems, Inc stock for Q4 2022, down 76% quarter-over-quarter.
- 3 funds opened new T2 Biosystems, Inc positions in Q4 2022 and 37 closed out, a net change of -34 holders.
- The largest T2 Biosystems, Inc buyer in Q4 2022 was McAdam LLC, an estimated $228K added.
- The largest T2 Biosystems, Inc seller in Q4 2022 was Altium Capital Management, an estimated $321K sold.
Based on aggregated 13F filings for Q4 2022.